SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test
Introduction
The SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test is a crucial diagnostic tool for identifying genetic mutations associated with Spinocerebellar Ataxia Type 17 (SCA17). This condition, characterized by progressive ataxia, can significantly impact an individual’s quality of life. Early detection through genetic testing allows for better management of symptoms and informed decision-making regarding treatment options.
What the Test Measures
This test specifically detects mutations in the TBP gene, which are known to cause SCA17. By analyzing the genetic material from a blood sample, the test identifies any alterations that could predispose an individual to this neurologic disorder.
Who Should Consider This Test?
Individuals who may benefit from this test include:
- Those with a family history of Spinocerebellar Ataxia or other neurologic disorders.
- Patients exhibiting symptoms such as balance issues, coordination problems, or unexplained neurological symptoms.
- Individuals seeking to understand their genetic risks for better health management.
Benefits of Taking the Test
Taking the SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test offers several advantages:
- Early diagnosis of potential genetic conditions.
- Informed decision-making regarding lifestyle changes and treatment options.
- Access to genetic counseling and support services.
- Contribution to ongoing research and understanding of neurologic disorders.
Understanding Your Results
Results from the SCA17 test will indicate whether a mutation in the TBP gene is present. A positive result suggests a higher risk of developing SCA17, while a negative result may provide reassurance. It is essential to discuss your results with a healthcare provider, preferably a neurologist, to understand the implications fully and explore potential management strategies.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test | 90,000 NGN | 160,000 NGN |
How to Book the Test
To schedule your SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any additional information you may need.
Sample Collection and Pre-Test Instructions
The sample required for this test is 4 mL (2 mL min.) of whole blood collected in a Lavender top (EDTA) tube. It is crucial to ship the sample refrigerated and not to freeze it. Additionally, a duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory for processing your test.
Turnaround Time
The results for the SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test are typically available within 10-12 days.
Take control of your health today with the SCA17 Spinocerebellar Ataxia TBP Gene Mutation Test. Understanding your genetic makeup can empower you to make informed health decisions.
